BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9069312)

  • 1. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
    Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
    Laing RW; Warrington AP; Graham J; Britton J; Hines F; Brada M
    Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
    Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B; Comber E; Maltenfort M; Dicker AP; Werner-Wasik M
    J Clin Oncol; 2010 Jun; 28(18):3048-53. PubMed ID: 20479391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
    McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
    J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
    BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
    Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L; Fisher B; Bauman G; Macdonald D
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report of a phase I study of combined fractionated stereotactic radiosurgery and conventional external beam radiation therapy for unfavorable gliomas.
    Regine WF; Patchell RA; Strottmann JM; Meigooni A; Sanders M; Young AB
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):421-6. PubMed ID: 10974456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control.
    Ogura K; Mizowaki T; Arakawa Y; Sakanaka K; Miyamoto S; Hiraoka M
    Cancer Med; 2013 Dec; 2(6):942-9. PubMed ID: 24403268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.
    Fields EC; Damek D; Gaspar LE; Liu AK; Kavanagh BD; Waziri A; Lillehei K; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):51-7. PubMed ID: 21035955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.
    Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
    J Neurooncol; 2007 Feb; 81(3):287-94. PubMed ID: 17031558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
    Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
    Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
    Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.